Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

Clinical trial NCT06709521 · COMPLETED

Trial details

NCT number: NCT06709521
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bacterial Infection

Start date: 2025-02-12
Primary completion: 2026-07-02
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.